Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness

The SARS-CoV-2 pandemic has produced an unprecedented rush to develop new therapies, ranging from immunizations and antivirals to host-directed therapies to dampen potentially deleterious host inflammatory responses. With a sense of urgency, many groups have proposed repurposing approved drugs for o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EBioMedicine
Hlavní autoři: Martin, Thomas R., Wurfel, Mark M., Zanoni, Ivan, Ulevitch, Richard
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305752/
https://ncbi.nlm.nih.gov/pubmed/32574958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102836
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky